Actively Recruiting
fMRI and Opioid Abstinence
Led by Yale University · Updated on 2025-10-20
240
Participants Needed
1
Research Sites
255 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
CONDITIONS
Official Title
fMRI and Opioid Abstinence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recent start of methadone or buprenorphine treatment at a clinic or program within the past year
- Eligible for MRI scanning
- Ability to commit to study visits
You will not qualify if you...
- Current acute psychosis, mania, or suicidal ideation with intent as assessed by SCID-5
- Current intoxication or acute withdrawal preventing participation based on observation, breathalyzer, and SOWS assessment
- Severe cognitive impairment indicated by PROMIS Cognitive Function tscore below 30 or during consent process
- Past or present intellectual disability, developmental disorder, or neurological disease
- Head trauma with loss of consciousness longer than 30 minutes
- Organ dysfunction or unstable or untreated medical conditions interfering with study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The APT Foundation
New Haven, Connecticut, United States, 06520
Actively Recruiting
Research Team
M
Monica Holler, BS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here